ST Pharm
ST Pharm
  • 01Who we are
  • 02Our record
  • 03Newsroom
  • 04Contact
    • En
    • Ko
ST Pharm
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
    • CI
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Update in progress
  • Sitemap
  • Linkedin
Public
ST PHARM News
  • PR (Public Relations)
    • News room
      • All
      • Media Focus
      • ST PHARM News
  • IR (Investor Relations)
    • Stock Information
    • IR Library
      • Disclosure Information
      • IR Materials
      • Notice

ST PHARM's Public Release

  • All
  • Media Focus
  • ST PHARM News
ST PHARM NewsST PHARM Acquired EcoVadis Silver Grade CertificationJul 11, 2022
ST PHARM NewsST PHARM Announces HIV-1 / AIDS Treatment Drug 'STP0404' Phase 1 Clinical Trial Results 'Positive and Safe'Jul 6, 2022
ST PHARM NewsST PHARM, Awarded 2022 Asia-Pacific Oligonucleotide CDMO Campany by Frost & SullivanMay 2, 2022
ST PHARM NewsST PHARM, Participated in TIDES USA 2022 Conference As a Gold sponsorMay 2, 2022
ST PHARM NewsST PHARM to Expand Oligonucleotide FacilityNov 29, 2021
ST PHARM NewsST PHARM Announces Expansion of Oligonucleotide Facility, Taking a Leap Towards the World's Largest Oligonucleotide CDMONov 29, 2021
ST PHARM NewsST PHARM Announces Publication of Preclinical Data for HIV-1 / AIIDS Treatment Drug 'STP0404'Jul 22, 2021
ST PHARM NewsST PHARM, The First Company Developing mRNA-LNP Vaccine in South KoreaJun 1, 2021
11of4
HOMEPublicPR (Public Relations)News roomST PHARM News
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
    • CI
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Update in progress
  • Privacy Policy
  • Terms of Use
  • Sitemap
  • Linkedin
© 2026 ST Pharm. All rights reserved.
  • Sitemap

We care about your privacy

This site uses essential cookies necessary for the operation of the service and for maintaining your language preferences. For more information, please review our Privacy Policy and Terms of Service.